Autor(en) Titel Quelle Links
Makras P, Samara C, Antoniou M, Zetos A, Papadogias D, Nikolakopoulou Z, Andreakos E, Toloumis G, Kontogeorgos G, Piaditis G, Kaltsas GA Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH). Neuroradiology 2006, 48: 37    
Makras P, Alexandraki KI, Chrousos GP, Grossman AB, Kaltsas GA Endocrine manifestations in Langerhans cell histiocytosis. Trends in endocrinology and metabolism: TEM 2007, 18: 252    
Makras P, Terpos E, Kanakis G, Papatheodorou A, Anastasilakis AD, Kokkoris P, Kaltsas GA Reduced bone mineral density in adult patients with Langerhans cell histiocytosis. Pediatric blood & cancer 2012, 58: 819    
Marsh RA, Allen CE, McClain KL, Weinstein JL, Kanter J, Skiles J, Lee ND, Khan SP, Lawrence J, Mo JQ, Bleesing JJ, Filipovich AH, Jordan MB Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatric blood & cancer 2013, 60: 101    
McClain KL Drug therapy for the treatment of Langerhans cell histiocytosis. Expert opinion on pharmacotherapy 2005, 6: 2435    
McClain K Bone and Soft Tissue Involvement - Oral Presentation at the Annual Meeting of the Histiocyte Society, Vienna. 2011.    
McClain K, Ramsay NK, Robison L, Sundberg RD, Nesbit M Jr Bone marrow involvement in histiocytosis X. Medical and pediatric oncology 1983, 11: 167    
McClain KL, Kozinetz CA A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatric blood & cancer 2007, 48: 44    
McCormack FX Lymphangioleiomyomatosis: a clinical update. Chest 2008, 133: 507    
Mendez JL, Nadrous HF, Vassallo R, Decker PA, Ryu JH Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest 2004, 125: 1028    
Micke O, Seegenschmiedt MH, German Working Group on Radiotherapy in Germany Consensus guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. International journal of radiation oncology, biology, physics 2002 Feb 1; 52: 496    
Minkov M, Grois N, Heitger A, Pötschger U, Westermeier T, Gadner H, DAL-HX Study Group Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Medical and pediatric oncology 2002, 39: 581    
Minkov M, Pötschger U, Grois N, Gadner H, Dworzak MN Bone marrow assessment in Langerhans cell histiocytosis. Pediatric blood & cancer 2007 Oct 15; 49: 694    
Minkov M, Grois N, McClain K, Nanduri V, Rodriguez-Galindo C, Simonitsch-Klupp I, Visser J, Weitzmann S, Whitlock J, Windebank K Langerhans Cell Histiocytosis - Histiocyte Society Evaluation and Treatment Guidelines. 2009. cited.    
Montella L, Merola C, Merola G, Petillo L, Palmieri G Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosis. Journal of bone and mineral metabolism 2009, 27: 110    
Montella L, Insabato L, Palmieri G Imatinib mesylate for cerebral Langerhans'-cell histiocytosis. The New England journal of medicine 2004 Sep 2; 351: 1034    
16 items found

The literature database is sorted by the first author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.